Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0072737 CO-CRYSTALS OF IBRUTINIB WITH CARBOXYLIC ACIDS
The present invention relates to co-crystals of ibrutinib, a pharmaceutical composition comprising the same as well as a method of preparing the same.
2018/0072736 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISOPROPYLPYRAZOLO4,3-D]PYRIMIDINE DERIVATIVES, USE...
5-substituted-7-[4-(2-pyridyl)phenylmethylamino]-3-isopropylpyrazolo[4,3-- d]pyrimidines are potent inhibitors of protein kinases, especially cyclin-dependent...
2018/0072735 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions...
2018/0072734 18F-LABELLED FOLATES AS PET RADIOTRACERS
The present invention is directed towards new .sup.18F-folate radiopharmaceuticals, wherein fluorine-18 is covalently linked to the glutamate portion of a...
2018/0072733 CRYSTALLINE FORM ALPHA OF IPI-145 AND PREPARATION METHOD THEREOF
The present disclosure relates to crystalline Form .alpha. of a compound of formula (I) used for preparing a blood-cancer drug and preparation method thereof....
2018/0072731 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND CARDIOMYOPATHY
Disclosed herein inter alia are compositions and methods useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity...
2018/0072730 NOVEL 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS...
The present invention relates to compounds of formula (I), ##STR00001## wherein R.sup.1, R.sup.2 and R.sup.3 are as described herein, and their prodrugs or...
2018/0072729 7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO [1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ONE, ANALOGS...
This disclosure relates to methods of treatment using compound (1) or analogs thereof, and pharmaceutically acceptable salts thereof. Also disclosed are...
2018/0072728 HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF
Disclosed are compounds of Formula (I) or a salt thereof, wherein: X is CR.sub.6 or N; W is: (i) --(CR.sub.3R.sub.3).sub.1-4-- or (ii) ...
2018/0072727 SPIROCYCLIC COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR
This invention relates to compounds that are agonists of the muscarinic M1 and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4...
2018/0072726 NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, W.sup.1, W.sup.2,...
2018/0072725 NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, W and X are as described...
2018/0072724 P2X7 MODULATORS
The present invention is directed to a compound of Formula (I) or (Ia) ##STR00001## The invention also relates to pharmaceutical compositions comprising ...
2018/0072723 KRAS G12C INHIBITORS
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the...
2018/0072722 HETEROCYCLIC COMPOUNDS AND USES THEREOF
Heterocyclic compounds of formula (I), methods for their preparation, pharmaceutical compositions containing such a compound and their therapeutic uses.
2018/0072721 NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5-DISUBSTITUTED-3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE...
The present invention provides compounds useful as c-Met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and...
2018/0072720 PYRAZOLOPYRIDINE COMPOUNDS AND USES THEREOF
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds....
2018/0072719 PYRAZOLOPYRIDONE COMPOUNDS AND USES THEREOF
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds....
2018/0072718 PYRAZOLOPYRIDINE COMPOUNDS AND USES THEREOF
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds....
2018/0072717 HETEROARYL CARBOXAMIDE COMPOUNDS AS INHIBITORS OF RIPK2
The present invention relates to compounds of formula (I): ##STR00001## or pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, X, Y, and HET are...
2018/0072716 NOVEL 5 OR 8-SUBSTITUTED IMIDAZO[1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
Disclosed herein are 5 or 8-substituted imidazo[1,5-a]pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted...
2018/0072715 IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS
Compounds of the formula (I), which are ATM kinase inhibitors and can be employed, inter alia, for the treatment of cancer.
2018/0072714 Novel Compounds
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, ##STR00001## wherein X.sup.1, X.sup.2, X.sup.3, Y.sup.1,...
2018/0072713 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES
The present invention relates to 1,3-thiazol-2-yl substituted benzamide compounds of general formula (I) as described and defined herein, to pharmaceutical...
2018/0072712 THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
Compounds having the following formula: ##STR00001## or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C--R.sup.7,...
2018/0072711 INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
The present disclosure relates to compounds and a pharmaceutically acceptable salt thereof, compositions, combinations and medicaments containing the...
2018/0072710 PHARMACOKINETICALLY IMPROVED COMPOUNDS
The present invention relates to inhibitors of ROCK1 and ROCK2 and methods of modulating the pharmacokinetic and/or pharmacodynamic properties of such...
2018/0072709 COMPOUND, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME, AND COLOR FILTER
A compound, a photosensitive resin composition including the compound, and a color filter manufactured using the photosensitive resin composition, the compound...
2018/0072708 NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME
An amyloid fibril formation inhibitor comprising a compound represented by the following general formulae (I) to (III): ##STR00001## wherein Q is...
2018/0072707 SUBSTITUTED 2-HYDROGEN-PYRAZOLE DERIVATIVE SERVING AS ANTICANCER DRUG
Disclosed is a substituted 2H-pyrazole derivative serving as a selective CDK4/6 inhibitor. Specifically, disclosed is a compound of formula (I) or a...
2018/0072706 AZD9291 INTERMEDIATE AND PREPARATION METHOD THEREFOR
Disclosed are an intermediate, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-formamidine]phenyl- -2-propenamide (II), applicable in preparing AZD9291...
2018/0072705 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical...
2018/0072704 Fused-Ring Or Tricyclic Aryl Pyrimidine Compound Used As Kinase Inhibitor
Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound...
2018/0072703 PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF RIPK2
The present invention relates to compounds of formula (I): ##STR00001## or pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, X, Y, and HET are...
2018/0072702 SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
The present invention relates to substituted 6,5-fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions...
2018/0072701 CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
A cyclic amine derivative represented by a general formula (I) or a pharmacologically acceptable salt thereof: ##STR00001## wherein n represents 1 or 3, R.sup.1...
2018/0072700 POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione are disclosed. Compositions comprising the polymorphic forms, methods of...
2018/0072699 PHOSPHOINOSITIDE 3-KINASE INHIBITORS
A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: R.sub.1, R.sub.2, R.sub.3, R and R.sub.6 are each independently (LQ).sub.mY;...
2018/0072698 COMPOUNDS HAVING ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS AND ANTI-INFLAMMATORY ACTIVITY, AND CORRESPONDING...
The invention relates to compounds having general formula (I): where R.dbd.H, CH.sub.2--OH, CH.sub.2--O--CO--CH.sub.3, CH.sub.2--O--CO--Ph (Ph=phenyl)...
2018/0072697 THERAPEUTIC COMPOUNDS
The invention provides compounds formula (I) and salts thereof: wherein the bond represented by ---- is a single bond or a double bond, and R1 has any of the...
2018/0072696 SUBSTITUTED 3-HYDROXY-DELTA-LACTONES FROM EPOXIDES
Catalysts and methods for the carbonylation of epoxides to substituted 3-hydroxy-.delta.-lactones and .beta.-lactones are disclosed.
2018/0072695 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF
Provided are a compound represented by Formula 1, and an organic electric element comprising a first electrode, a second electrode, and an organic material...
2018/0072694 FUSED HETEROCYCLIC COMPOUND
The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect, and use of the compound as a medicament for...
2018/0072693 METHOD FOR SYNTHESIZING A PRECURSOR OF A SINGLE DAIRY-LACTONE ISOMER
This disclosure provides a method for preparing a precursor of a single dairy-lactone isomer, methods of preparing a single dairy-lactone isomer, and to the...
2018/0072692 PROCESS FOR THE PRODUCTION OF 1,4-BUTANEDIOL AND TETRAHYDROFURAN FROM FURAN
The present invention provides a process for the production of THF and 1,4-BDO from furan in the presence of a catalytic composition, wherein the catalytic...
2018/0072691 METHODS OF PRODUCING AN HIV MATURATION INHIBITOR
A method for producing HIV maturation inhibitor compound is set forth using betulin ##STR00001## as starting material, and utilizing Lossen rearrangement...
2018/0072690 Methods for Making Serotonin Reuptake Inhibitors
The present invention relates to a process for preparing serotonin reuptake inhibitors of formula (I) and pharmaceutically acceptable salts thereof, (Formula...
2018/0072689 1,2,4-Oxadiazole Derivatives as Immunomodulators
The present invention relates to synthetic methods for 1,2,4-oxadiazole compounds. The general synthetic scheme is: ##STR00001## R.sub.1 substituents generally...
2018/0072688 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.
2018/0072687 HETEROARYL COMPOUNDS AND USES THEREOF
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.